substance ABUSE

Pathways proprietary combination gene therapy and drug approach targets a master reward regulatory pathway in the brain that has been proven to exist not only in higher mammals, but also in test animals that have been trained to mimic human alcoholism disease.

Pathways Neuro Pharma's main focus is on the specific behavior patterns in the brain, which lie at the intersection of neurological pathways at the heart of alcoholism and  addicton in order to uncover ways to:

• Treat substance abuse as a disease, not a moral weakness;
• Use the latest advancement in brain imaging;
• Understand neural pathways involved in reward processing;
• Develop pharmaceutical activators of these regulations; and
• Pioneer combination therapy to synergistically treat patients.